OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
July 08, 2010
The US House of Representatives passed on July 1, 2010, HR 4899, the Supplemental Appropriations Act of 2010, which included provisions restricting patent settlements between innovator-drug and generic-drug companies, a move that drew criticism from both sectors of the pharmaceutical industry.
July 07, 2010
The US government outlines its strategy against counterfeiting and intellectual-property infringement, including ways to better secure the pharmaceutical supply chain.
Led by sustainability efforts by Walmart, a new tool emerges for quickly evaluating the environmental and human-health profile of formulated products.
Acumen Fund, a nonprofit venture-capital fund, uses patient capital to build economically sustainable businesses involved in poverty alleviation.
July 02, 2010
Nanotechnology is an important area of drug and biomedical research, and advancing nano-analysis is crucial for its further development.
Excipient manufacturers expand their products, services, manufacturing capacity, and technology positions.